Evidence map›Paper›PMID 37736437›Full record

ArticleCureus2023

Secukinumab-Induced Crohn's Disease in a Patient Treated for Juvenile Idiopathic Arthritis.

Srujan Edupuganti, Su Khine, Rohit Gupta, Deepesh Yadav, Adiraj Singh

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Srujan EdupugantiInternal Medicine/Pediatrics, Michigan State University College of Human Medicine, Hurley Medical Center, Flint, USA.
Su KhineInternal Medicine, Michigan State University College of Human Medicine, Hurley Medical Center, Flint, USA.
Rohit GuptaInternal Medicine/Pediatrics, Michigan State University College of Human Medicine, Hurley Medical Center, Flint, USA.
Deepesh YadavRheumatology, University of Arkansas for Medical Sciences, Little Rock, USA.
Adiraj SinghInternal Medicine/Pediatrics, Michigan State University College of Human Medicine, Hurley Medical Center, Flint, USA.
Dhulikhel Hospital · NPHurley Medical Center · USUniversity of Arkansas for Medical Sciences · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Juvenile idiopathic arthritis (JIA) is a common form of arthritis that occurs in children, typically with an onset before the age of 16 years. It can affect joints in any part of the body. As per the International League of Rheumatology, JIA is classified into systemic arthritis, oligoarthritis, extended oligoarthritis, polyarthritis (rheumatoid factor positive), polyarthritis (rheumatoid factor negative), enthesitis-related arthritis (ERA), juvenile psoriatic arthritis (JPsA), and

Indexed as

crohn's diseaseibdil-17il-17ainflammatory bowel diseaseinterleukin-17interleukin-17a blockersjiajuvenile idiopathic arthritissecukinumab

Identifiers

PMID37736437
PMCPMC10509381
OpenAlexW4386029507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.